# FY22. DRUG PRODUCT STABILITY STUDIES. POP 9/23/22 - 9/22/23.

> **NIH NIH N01** · MURTY PHARMACEUTICALS, INC. · 2022 · $88,415

## Abstract

Substance Misuse

## Key facts

- **NIH application ID:** 10721026
- **Project number:** 75N95021D00024-0-759502200001-1
- **Recipient organization:** MURTY PHARMACEUTICALS, INC.
- **Principal Investigator:** SANTOS MURTY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $88,415
- **Award type:** —
- **Project period:** 2022-09-23 → 2023-09-22

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10721026

## Citation

> US National Institutes of Health, RePORTER application 10721026, FY22. DRUG PRODUCT STABILITY STUDIES. POP 9/23/22 - 9/22/23. (75N95021D00024-0-759502200001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10721026. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*